Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Time: 4:30 p.m. ET About Profound Medical Corp. Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve® has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fib ...